Brian Richard Mac Donald Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

Brian Richard Mac Donald is Chief Innovation Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 12,876 shares of GMTX, which is worth approximately $313,788. The most recent transaction as insider was on Jun 30, 2023, when has been sold 4,324 shares (Common Stock) at a price of $45.15 per share, resulting in proceeds of $195,228. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.9K
0% 3M change
0% 12M change
Total Value Held $313,788

Brian Richard MacDonald Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2023
SELL
Open market or private sale
$195,228 $45.15 p/Share
4,324 Reduced 25.14%
12,876 Common Stock
Jun 30 2023
BUY
Open market or private sale
$28,056 $46.76 p/Share
600 Added 4.66%
12,276 Common Stock
Jun 29 2023
SELL
Open market or private sale
$234,090 $45.9 p/Share
5,100 Reduced 22.87%
17,200 Common Stock
Jun 28 2023
SELL
Open market or private sale
$255,714 $50.14 p/Share
5,100 Reduced 18.61%
22,300 Common Stock
BRM

Brian Richard Mac Donald

Chief Innovation Officer
Watertown, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX